CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 834 of 865
Non-Antibody Products
Page 834 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Uridine-5'-monophosphate | A ribonucleotide | 500 mg | 35382-500 | More Info |
| Uridine-3'-monophosphate (sodium salt) | A nucleoside used in the biochemical synthesis of ribothymidine-3'-phospha… | 10 mg | 16774-10 | More Info |
| Uridine-3'-monophosphate (sodium salt) | A nucleoside used in the biochemical synthesis of ribothymidine-3'-phospha… | 25 mg | 16774-25 | More Info |
| Uridine-3'-monophosphate (sodium salt) | A nucleoside used in the biochemical synthesis of ribothymidine-3'-phospha… | 5 mg | 16774-5 | More Info |
| Uridine-3'-monophosphate (sodium salt) | A nucleoside used in the biochemical synthesis of ribothymidine-3'-phospha… | 50 mg | 16774-50 | More Info |
| Uridine-5'-monophosphate (sodium salt hydrate) | A ribonucleotide | 1 g | 34525-1 | More Info |
| Uridine-5'-monophosphate (sodium salt hydrate) | A ribonucleotide | 10 g | 34525-10 | More Info |
| Uridine-5'-monophosphate (sodium salt hydrate) | A ribonucleotide | 5 g | 34525-5 | More Info |
| Uridine-5'-O-triphosphoro-γ-1-(5-sulfonic acid)naphthylamidate (sodium salt) | A fluorescent derivative of UTP; has been used in HTS assays for inhibitor… | 3.4 mg | 38574-34 | More Info |
| URMC-099 | An orally bioavailable, brain-penetrant inhibitor of MLKs (IC50s = 19, 42,… | 10 mg | 19147-10 | More Info |
| URMC-099 | An orally bioavailable, brain-penetrant inhibitor of MLKs (IC50s = 19, 42,… | 25 mg | 19147-25 | More Info |
| URMC-099 | An orally bioavailable, brain-penetrant inhibitor of MLKs (IC50s = 19, 42,… | 5 mg | 19147-5 | More Info |
| UR-144 N-(5-bromopentyl) analog | Differs from UR-144 by having a bromine atom on the terminal carbon of the… | 1 mg | 12003-1 | More Info |
| UR-144 N-(5-bromopentyl) analog | Differs from UR-144 by having a bromine atom on the terminal carbon of the… | 10 mg | 12003-10 | More Info |
| UR-144 N-(5-bromopentyl) analog | Differs from UR-144 by having a bromine atom on the terminal carbon of the… | 5 mg | 12003-5 | More Info |
| UR-144 N-(2-chloropentyl) analog | A synthetic CB which differs from the parent compound, UR-144, by the addi… | 1 mg | 13115-1 | More Info |
| UR-144 N-(2-chloropentyl) analog | A synthetic CB which differs from the parent compound, UR-144, by the addi… | 100 µg | 13115-100 | More Info |
| UR-144 N-(2-chloropentyl) analog | A synthetic CB which differs from the parent compound, UR-144, by the addi… | 500 µg | 13115-500 | More Info |
| UR-144 N-(4-chloropentyl) analog | A synthetic CB that differs from the parent compound, UR-144, by the addit… | 1 mg | 13117-1 | More Info |
| UR-144 N-(4-chloropentyl) analog | A synthetic CB that differs from the parent compound, UR-144, by the addit… | 100 µg | 13117-100 | More Info |
| UR-144 N-(4-chloropentyl) analog | A synthetic CB that differs from the parent compound, UR-144, by the addit… | 500 µg | 13117-500 | More Info |
| UR-144 N-(5-chloropentyl) analog | Differs from UR-144 by having a chlorine atom on the terminal carbon of th… | 1 mg | 11951-1 | More Info |
| UR-144 N-(5-chloropentyl) analog | Differs from UR-144 by having a chlorine atom on the terminal carbon of th… | 10 mg | 11951-10 | More Info |
| UR-144 N-(5-chloropentyl) analog | Differs from UR-144 by having a chlorine atom on the terminal carbon of th… | 5 mg | 11951-5 | More Info |
| UR-144 N-heptyl analog | Differs from UR-144 by having two additional carbons in the alkyl group; i… | 1 mg | 14231-1 | More Info |
| UR-144 N-heptyl analog | Differs from UR-144 by having two additional carbons in the alkyl group; i… | 10 mg | 14231-10 | More Info |
| UR-144 N-heptyl analog | Differs from UR-144 by having two additional carbons in the alkyl group; i… | 5 mg | 14231-5 | More Info |
| UR-144 N-(5-hydroxypentyl) β-D-Glucuronide | An expected major urinary metabolite of UR-144, based on the metabolism of… | 1 mg | 11776-1 | More Info |
| UR-144 N-(5-hydroxypentyl) β-D-Glucuronide | An expected major urinary metabolite of UR-144, based on the metabolism of… | 500 µg | 11776-500 | More Info |
| UR-144 N-(2-hydroxypentyl) metabolite | A synthetic CB that differs from the parent compound, UR-144, by the addit… | 1 mg | 14470-1 | More Info |
| UR-144 N-(2-hydroxypentyl) metabolite | A synthetic CB that differs from the parent compound, UR-144, by the addit… | 10 mg | 14470-10 | More Info |
| UR-144 N-(2-hydroxypentyl) metabolite | A synthetic CB that differs from the parent compound, UR-144, by the addit… | 5 mg | 14470-5 | More Info |
| UR-144 N-(4-hydroxypentyl) metabolite | An expected phase I metabolite of UR-144; should be detectable in either s… | 1 mg | 11774-1 | More Info |
| UR-144 N-(4-hydroxypentyl) metabolite | An expected phase I metabolite of UR-144; should be detectable in either s… | 10 mg | 11774-10 | More Info |
| UR-144 N-(4-hydroxypentyl) metabolite | An expected phase I metabolite of UR-144; should be detectable in either s… | 5 mg | 11774-5 | More Info |
| UR-144 N-(5-hydroxypentyl) metabolite | An expected phase I metabolite of UR-144, based on the metabolism of simil… | 1 mg | 11775-1 | More Info |
| UR-144 N-(5-hydroxypentyl) metabolite | An expected phase I metabolite of UR-144, based on the metabolism of simil… | 10 mg | 11775-10 | More Info |
| UR-144 N-(5-hydroxypentyl) metabolite | An expected phase I metabolite of UR-144, based on the metabolism of simil… | 5 mg | 11775-5 | More Info |
| UR-144 N-(4-hydroxypentyl) metabolite-d5 | An internal standard for the quantification of UR-144 N-(4-hydroxypentyl)… | 1 mg | 14374-1 | More Info |
| UR-144 N-(4-hydroxypentyl) metabolite-d5 | An internal standard for the quantification of UR-144 N-(4-hydroxypentyl)… | 500 µg | 14374-500 | More Info |
| UR-144 N-(5-hydroxypentyl) metabolite-d5 | An internal standard for the quantification of UR-144 N-(5-hydroxypentyl)… | 1 mg | 14375-1 | More Info |
| UR-144 N-(5-hydroxypentyl) metabolite-d5 | An internal standard for the quantification of UR-144 N-(5-hydroxypentyl)… | 100 µg | 14375-100 | More Info |
| UR-144 N-(5-hydroxypentyl) metabolite-d5 | An internal standard for the quantification of UR-144 N-(5-hydroxypentyl)… | 500 µg | 14375-500 | More Info |
| UR-144 N-(5-methylhexyl) analog | Differs from UR-144 by having a methyl group at the end of the alkane chain | 1 mg | 9001439-1 | More Info |
| UR-144 N-(5-methylhexyl) analog | Differs from UR-144 by having a methyl group at the end of the alkane chain | 10 mg | 9001439-10 | More Info |
| UR-144 N-(5-methylhexyl) analog | Differs from UR-144 by having a methyl group at the end of the alkane chain | 5 mg | 9001439-5 | More Info |
| UR-144 N-pentanoic acid metabolite | An expected phase I metabolite of UR-144; should be detectable in either s… | 1 mg | 11773-1 | More Info |
| UR-144 N-pentanoic acid metabolite | An expected phase I metabolite of UR-144; should be detectable in either s… | 10 mg | 11773-10 | More Info |
| UR-144 N-pentanoic acid metabolite | An expected phase I metabolite of UR-144; should be detectable in either s… | 5 mg | 11773-5 | More Info |
| UR-144 N-pentanoic acid metabolite-d5 | An internal standard for the quantification of UR-144 N-pentanoic acid met… | 1 mg | 14376-1 | More Info |
| UR-144 N-pentanoic acid metabolite-d5 | An internal standard for the quantification of UR-144 N-pentanoic acid met… | 5 mg | 14376-5 | More Info |
| UR-144 N-pentanoic acid metabolite-d5 | An internal standard for the quantification of UR-144 N-pentanoic acid met… | 500 µg | 14376-500 | More Info |
| Urobilin (hydrochloride) | A byproduct of hemoglobin degradation; formed via oxidation of urobilinoge… | 1 mg | 36508-1 | More Info |
| Urobilin (hydrochloride) | A byproduct of hemoglobin degradation; formed via oxidation of urobilinoge… | 5 mg | 36508-5 | More Info |
| Urocortin (human) (trifluoroacetate salt) | A neuropeptide hormone; binds to type 1 and 2 CRF receptors as well as CRF… | 1 mg | 24744-1 | More Info |
| Urocortin (human) (trifluoroacetate salt) | A neuropeptide hormone; binds to type 1 and 2 CRF receptors as well as CRF… | 500 µg | 24744-500 | More Info |
| Urocortin II (human) (trifluoroacetate salt) | A neuropeptide hormone; increases cell shortening and accelerates relaxati… | 1 mg | 24746-1 | More Info |
| Urocortin II (human) (trifluoroacetate salt) | A neuropeptide hormone; increases cell shortening and accelerates relaxati… | 500 µg | 24746-500 | More Info |
| Urocortin III (human) (trifluoroacetate salt) | A neuropeptide hormone; selectively binds to type 2 CRF receptors (Kis = 2… | 1 mg | 24748-1 | More Info |
| Urocortin III (human) (trifluoroacetate salt) | A neuropeptide hormone; selectively binds to type 2 CRF receptors (Kis = 2… | 500 µg | 24748-500 | More Info |
| Urocortin III (mouse) (trifluoroacetate salt) | A neuropeptide hormone; expressed in the hypothalamus, brainstem, and LS /… | 500 µg | 24749-500 | More Info |
| Urocortin III (mouse) (trifluoroacetate salt) | A neuropeptide hormone; expressed in the hypothalamus, brainstem, and LS /… | 1 mg | 24750-1 | More Info |
| Urocortin III (mouse) (trifluoroacetate salt) | A neuropeptide hormone; expressed in the hypothalamus, brainstem, and LS /… | 500 µg | 24750-500 | More Info |
| Urocortin II (mouse) (trifluoroacetate salt) | A neuropeptide hormone; selectively binds to CRF1 over CRF2 receptors (Kis… | 500 µg | 24747-500 | More Info |
| Urocortin (rat) (trifluoroacetate salt) | A neuropeptide hormone; binds to type 1 and 2 CRF receptors as well as CRF… | 1 mg | 24745-1 | More Info |
| Urodilatin | A renal natriuretic peptide that regulates sodium and water reabsorption i… | 1 mg | 17400-1 | More Info |
| Urodilatin | A renal natriuretic peptide that regulates sodium and water reabsorption i… | 500 µg | 17400-500 | More Info |
| Urolithin A | A metabolite of ellagic acid with antiproliferative, anti-inflammatory, an… | 1 mg | 22607-1 | More Info |
| Urolithin A | A metabolite of ellagic acid with antiproliferative, anti-inflammatory, an… | 10 mg | 22607-10 | More Info |
| Urolithin A | A metabolite of ellagic acid with antiproliferative, anti-inflammatory, an… | 25 mg | 22607-25 | More Info |
| Urolithin A | A metabolite of ellagic acid with antiproliferative, anti-inflammatory, an… | 5 mg | 22607-5 | More Info |
| Urolithin B | A metabolite of ellagic acid; reduces AGE levels in a cell-free assay in a… | 1 g | 33757-1 | More Info |
| Urolithin B | A metabolite of ellagic acid; reduces AGE levels in a cell-free assay in a… | 5 g | 33757-5 | More Info |
| Urolithin B | A metabolite of ellagic acid; reduces AGE levels in a cell-free assay in a… | 500 mg | 33757-500 | More Info |
| Urotensin II (goby) (trifluoroacetate salt) | A peptide vasoconstrictor and agonist of the UT receptor (Ki = 2.06 nM for… | 1 mg | 24753-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile